Evidence method
Level · gp.fundamentals.capex_revenue_ratio
20.74% · OPTIONAL · VALID
PULSE BIOSCIENCES, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
20.74% · OPTIONAL · VALID
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-4310.83% · OPTIONAL · VALID
Level · gp.fundamentals.inventory_revenue_ratio
54.38% · OPTIONAL · VALID
Level · gp.fundamentals.gross_margin
37.10% · CORE · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.operating_margin
-5823.04% · CORE · VALID
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3911.52% · OPTIONAL · VALID
Level · gp.fundamentals.sbc_revenue_ratio
1145.85% · OPTIONAL · VALID
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.